Perioperative single photon emission computed tomography in predicting survival of malignant glioma patients

Oncology Letters

Volumn 4, Issue 4, 2012, Pages 739-744

  Deltuva, Vytenis ^a   Bunevicius, Adomas ^a   Jurkiene, Nemira ^a   Kulakiene, Ilona ^a   Tamasauskas, Arimantas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Glioma; Single photon emission tomography; Survival

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLIOBLASTOMA; GLIOSARCOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; LOG RANK TEST; MALE; MULTIVARIATE ANALYSIS; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; RADICAL RESECTION; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIVARIATE ANALYSIS;

EID: 84864700948     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.812     Document Type: Article

References (29)

1. DeAngelis LM: Brain tumors. N Engl J Med 344: 114-23, 2001.
2. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2: 494-503, 2006.
3. Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, et al: Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol 28: 2467-2474, 2010.
4. Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, et al: Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46: 183-188, 1999.
5. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
6. Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, et al: Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J Neurosurg 89: 425-430, 1998.
7. Lutterbach J, Guttenberger R, Pagenstecher A: Gliosarcoma: a clinical study. Radiother Oncol 61: 57-64, 2001.
8. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, et al: Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 18: 1061-1083, 2009.
9. Chaichana K, Parker S, Olivi A and Quiñones-Hinojosa A: A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112: 997-1004, 2010.
10. El Hindy N, Bachmann HS, Lambertz N, Adamzik M, Nückel H, Worm K, et al: Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme. J Neurosurg 114: 1631-1639, 2011.
11. Cheng X, Li Y, Xu Z, Li D and Wang J: A meta-analysis of (99m)Tc-MIBI SPECT for detection of recurrent glioma after radiation therapy. J Clin Neurosci 18:307-312, 2011.
12. Kallén K, Burtscher IM, Holtås S, Ryding E and Rosén I: 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas. J Neurooncol 46: 173-185, 2000.
13. Prigent-Le Jeune F, Dubois F, Perez S, Blond S and Steinling M: Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results. Eur J Nucl Med Mol Imaging 31: 714-719, 2004.
14. Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, et al: Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 89: 60-68, 1998.
15. Ak I, Gulbas Z, Altinel F and Vardareli E: Tc-99m MIBI uptake and its relation to the proliferative potential of brain tumors. Clin Nucl Med 28: 29-33, 2003.
16. Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia A, Voulgaris S, et al: The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme. J Nucl Med 51: 1923-1926, 2010.
17. Beauchesne P, Pedeux R, Boniol M and Soler C: 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med 45: 409-413, 2004.
18. Beauchesne P and Soler C: Correlation of 99mTc-MIBI brain spect (functional index ratios) and survival after treatment failure in malignant glioma patients. Anticancer Res 22: 3081-3085, 2002.
19. Nagamachi S, Jinnouchi S, Nabeshima K, Nishii R, Flores L II, Kodama T, et al: The correlation between 99mTc-MIBI uptake and MIB-1 as a nuclear proliferation marker in glioma - a comparative study with 201Tl. Neuroradiology 43: 1023-1030, 2001.
20. Deltuva VP, Jurkiene N, Kulakiene I, Bunevicius A, Matukevicius A and Tamasauskas A: Introduction of novel semi-quantitative evaluation of 99mTc-MIBI SPECT before and after treatment for glioma. Medicina (Kaunas) 48 (1): 15-21, 2012.
21. Filippi L, Santoni R, Manni C, Danieli R, Floris R and Schillaci O: Imaging primary bain tumors by single-photon emission computerized tomography (SPECT) with technetium-99m sestabimi (MIBI) and tetrofosmin. Current Medical Imaging Reviews 1: 61-66, 2005.
22. Henkin RE, Bova D, Dillehay GL, Halama JR, Karesh SM, Wagner RH, et al (eds): Nuclear Medicine. 2nd edition. Mosby Elsevier, Philadelphia, pp 137-153, 2006.
23. Semba T, Sugawara Y, Ochi T, Fujii T, Mochizuki T and Ohnishi T: Thallium-201 SPECT in prognostic assessment of malignant gliomas treated with postoperative radiotherapy. Ann Nucl Med 20: 287-294, 2006.
24. Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, et al: Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 64: 227-237, 2003.
25. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, et al: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816-822, 1985.
26. Chen WS, Luker KE, Dahlheimer JL, Pica CM, Luker GD and Piwnica-Worms D: Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin. Biochem Pharmacol 60: 413-426, 2000.
27. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A and Jones AG: Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 50: 2198-202, 1990.
28. Pichlmeier U, Bink A, Schackert G, Stummer W; ALA Glioma Study Group: Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10: 1025-1034, 2008.
29. Sanai N, Polley MY, McDermott MW, Parsa AT and Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115: 3-8, 2011.